There was no significant difference in the frequency of CD11c+CD8+ T cells and the levels of CD38&HLA-DR, PD-1, and GB expression of CD11c+CD8+ T cells between the HCC and HC groups (Figures 2A–D). The gene discussed is CD38; the disease is hepatocellular carcinoma.